Paris-based Mauna Kea Technologies' confocal laser endomicroscopy platform Cellvizio matches histologic diagnostic findings in relation to major gastrointestinal diseases.
GI & Endoscopy
Greensburg, Pa.-based Allegheny Health Network is planning a 23,000-square-foot multispecialty facility with an endoscopy center.
Researchers presented a study at the American Association for Cancer Research's Annual Meeting, April 3, 2017 in Washington, D.C., that examined the effect pesticide exposure plays in developing cancer, Live Science reports.
The New York City-based Crohn's & Colitis Foundation and the American Gastroenterological Association, in collaboration with New York City-based Pfizer, are developing a program to improve patient-provider communication on inflammatory bowel disease.
Here are six updates on GI companies:
Advertisement
Truc Trinh, MD, is a gastroenterologist with Arlington-based Gastroenterology Center of Northern Virginia.
Osaka, Japan-based Takeda Pharmaceuticals entered into a strategic collaboration with Teaneck, N.J.-based NuBiyota for its microbial ecosystem therapeutic products.
A study in Inflammatory Bowel Diseases found communication on quality of life outcomes is poor between ulcerative colitis patients and their gastroenterologists.
A study published in the Journal of Clinical Investigation examined peroxisome proliferator-activated receptor y's transcription role in liver tumorigenesis, which was previously unknown.
A study published in Science examined reoviruses' effect on immune systems and dietary antigens.